Mouse model of touch-evoked itch (alloknesis)

Area of Science:

• Neuroscience
• Dermatology
• Pruritus Research

Background:

• Alloknesis, the sensation of itch triggered by non-itch stimuli, is a common but poorly understood phenomenon.
• Investigating the neural pathways underlying alloknesis is crucial for developing effective itch treatments.

Purpose of the Study:

• To establish and validate a novel animal model for studying the neural mechanisms of alloknesis.
• To identify specific neurochemical pathways involved in histamine-induced alloknesis.

Main Methods:

• Development of an animal model using C57/BL6 mice.
• Intradermal injection of histamine and other pruritogens (5-HT, PAR-4 agonist, MrgprC11 agonist) to induce itch.
• Low-threshold mechanical stimulation applied near injection sites to assess touch-evoked scratching.
• Pharmacological interventions using naltrexone and terfenadine to probe receptor involvement.

Main Results:

• Mechanical stimulation near histamine injection sites elicited hindlimb scratching, mimicking alloknesis.
• Histamine- and touch-evoked scratching were inhibited by naltrexone, suggesting opioid involvement.
• Touch-evoked scratching was induced by 5-HT, PAR-4, and MrgprC11 agonists, but not PAR-2 agonists or chloroquine.
• Terfenadine blocked histamine-evoked scratching and alloknesis, but not that induced by other agonists.
• Experimental dry skin in mice increased spontaneous and touch-evoked scratching.

Conclusions:

• The developed mouse model effectively replicates histamine-induced alloknesis and touch-evoked scratching.
• Histamine H1 receptors and opioid pathways play significant roles in mediating alloknesis.
• The model provides a valuable tool for exploring the neurobiology of itch and alloknesis.